Alagille syndrome (NORD)

00:00 / 00:00



Alagille syndrome (NORD)

Information for patients and families

The National Organization for Rare Disorders (NORD)

Recurrent pericarditis (NORD)

Autoimmune polyglandular syndrome type 1 (NORD)

Opsoclonus myoclonus syndrome (NORD)

Thyroid eye disease (NORD)

Bile synthesis disorders (NORD)

Cyclic vomiting syndrome (NORD)

Eosinophilic esophagitis (NORD)

Short bowel syndrome (NORD)

Essential thrombocythemia (NORD)

Myelofibrosis (NORD)

Polycythemia vera (NORD)

Sickle cell disease (NORD)

Waldenstrom macroglobulinemia (NORD)

Warm autoimmune hemolytic anemia and cold agglutinin (NORD)

Congenital athymia (NORD)

Cytomegalovirus infection after transplant (NORD)

Post-transplant lymphoproliferative disorders (NORD)

Severe chronic neutropenia (NORD)

Adrenoleukodystrophy (NORD)

Alagille syndrome (NORD)

Aromatic L-amino acid decarboxylase deficiency (NORD)

Cerebrotendinous xanthomatosis (NORD)

Classical homocystinuria (NORD)

Congenital cytomegalovirus (NORD)

Cystinuria (NORD)

Fabry disease (NORD)

Gaucher disease (NORD)

Glycogen storage disease type II (NORD)

Metachromatic leukodystrophy (NORD)

Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)

Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)

Mycobacterium avium complex (NORD)

NGLY1 deficiency (NORD)

Niemann-Pick disease types A and B (NORD)

Phenylketonuria (NORD)

PIK3CA-related overgrowth spectrum (NORD)

Tay-Sachs disease (NORD)

Zellweger spectrum disorders (NORD)

Early infantile epileptic encephalopathy (NORD)

Opsoclonus myoclonus syndrome (NORD)

Spinocerebellar ataxia (NORD)

Narcolepsy (NORD)

Focal segmental glomerulosclerosis (NORD)

IgA nephropathy (NORD)

Pulmonary arterial hypertension (NORD)

High Yield Notes

7 pages


Alagille syndrome, or ALGS, is a genetic disorder that can affect multiple organs in the body and cause a variety of abnormalities.

Alagille syndrome typically affects the liver but it can also cause problems in the heart, kidney, eyes, and bones.

One of the main liver features of Alagille syndrome is the disruption of bile flow from the liver to the gallbladder.

Affected individuals have a reduced number of bile ducts in the liver.

As a result, there is a decrease in bile flow, also known as cholestasis.

The symptoms and signs of cholestasis include jaundice, or the yellowing of skin and eyes, severe itching, pale colored stools, and dark urine.

Some patients may also have an enlarged spleen or liver.

Because many necessary vitamins and nutrients need bile to be properly absorbed, people with Alagille syndrome may also experience select vitamin deficiencies, or poor weight gain and growth.

Deficiencies in specific vitamins may result in vision problems from a lack of Vitamin A, bone weakness from a lack of vitamin D, developmental delays from a lack of Vitamin E, and blood clotting problems from a lack of Vitamin K.

The heart can also be impacted by Alagille syndrome.

The most common finding in ALGS patients is peripheral pulmonary arterial stenosis.

This means that the blood vessels carrying blood to the lungs are narrowed.

The stenosis typically manifests as a heart murmur, or an extra sound in the heartbeat.

Symptoms are based on the degree of narrowing of the blood vessel and some people may have no symptoms while others may have dizziness, shortness of breath, increased sweating, chest pains, and cyanosis, or bluish colored skin.


Alagille syndrome (NORD) is a rare, autosomal dominant disorder that affects the liver, heart, and other parts of the body. The most common symptom of Alagille syndrome is jaundice (yellowing of the skin and eyes) in infancy. Other symptoms may include malformed bones, kidney problems, and irregular developmental milestones. There is no cure for Alagille syndrome, but many affected individuals can lead normal, productive lives with proper care.


Copyright © 2023 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.